LETROZOLE-WT letrozole 2.5 mg tablet blister pack

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

letrozole, Quantity: 2.5 mg

متاح من:

Medis Pharma Pty Ltd

INN (الاسم الدولي):

Letrozole

الشكل الصيدلاني:

Tablet, film coated

تركيب:

Excipient Ingredients: lactose monohydrate; maize starch; sodium starch glycollate; iron oxide yellow; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400

طريقة التعاطي:

Oral

الوحدات في الحزمة:

30

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

Treatment of postmenopausal women with hormone receptor positive breast cancer (see "Clinical Trials"). The safety and efficacy of neoadjuvant use has not been established. Letrozole is not indicated in hormone receptor negative disease.

ملخص المنتج:

Visual Identification: Yellow to dark yellow round, film coated, biconvex tablet engraved with ' L' on one face and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

الوضع إذن:

Licence status A

تاريخ الترخيص:

2013-05-20